Inventor · disambiguated record
Bryan D. Lemon
Also filed as: LEMON BRYAN · LEMON BRYAN D
23 granted patents·15 pending applications·216 citations·filing 2012–2024
95Inventor score
Top patents by PatentIndex Score
38 records- 0196US10543271B2Mesothelin binding proteinsHARPOON THERAPEUTICS INC·Filed 2018·Granted Jan 28, 2020·13 cites·18 claims
- 0296US10100106B2Single domain serum albumin binding proteinHARPOON THERAPEUTICS INC·Filed 2017·Granted Oct 16, 2018·27 cites·26 claims
- 0396US9920115B2Single domain serum albumin binding proteinHARPOON THERAPEUTICS INC·Filed 2017·Granted Mar 20, 2018·31 cites·12 claims
- 0495US11085021B2Compositions and methods for TCR reprogramming using fusion proteinsTCR2 THERAPEUTICS INC·Filed 2020·Granted Aug 10, 2021·3 cites·27 claims
- 0595US10849973B2Prostate specific membrane antigen binding proteinHARPOON THERAPEUTICS INC·Filed 2017·Granted Dec 1, 2020·10 cites·8 claims
- 0695US10844134B2PSMA targeting trispecific proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2017·Granted Nov 24, 2020·12 cites·11 claims
- 0795US10730954B2MSLN targeting trispecific proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2018·Granted Aug 4, 2020·14 cites·2 claims
- 0895US10066016B2Single chain variable fragment CD3 binding proteinsHARPOON THERAPEUTICS INC·Filed 2017·Granted Sep 4, 2018·34 cites·13 claims
- 0994US11136403B2Trispecific proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2018·Granted Oct 5, 2021·11 cites·13 claims
- 1094US10927180B2B cell maturation antigen binding proteinsHARPOON THERAPEUTICS INC·Filed 2018·Granted Feb 23, 2021·8 cites·18 claims
- 1192US10544221B2Single chain variable fragment CD3 binding proteinsHARPOON THERAPEUTICS INC·Filed 2017·Granted Jan 28, 2020·14 cites·17 claims
- 1292US9714276B2Growth differentiation factor 15 (GDF-15) polypeptidesAMGEN INC·Filed 2013·Granted Jul 25, 2017·17 cites·18 claims
- 1391US10336798B2Growth differentiation factor 15 (GDF-15) polypeptidesAMGEN INC·Filed 2017·Granted Jul 2, 2019·9 cites·21 claims
- 1487US10059766B2Antibody constructs for CDH19 and CD3AMGEN RES MUNICH GMBH·Filed 2014·Granted Aug 28, 2018·9 cites·17 claims
- 1584US11739131B2Growth differentiation factor 15 (GDF-15) polypeptidesAMGEN INC·Filed 2019·Granted Aug 29, 2023·1 cites·6 claims
- 1681US11623958B2Single chain variable fragment CD3 binding proteinsHARPOON THERAPEUTICS INC·Filed 2020·Granted Apr 11, 2023·1 cites·24 claims
- 1780US11453716B2Single domain serum albumin binding proteinHARPOON THERAPEUTICS INC·Filed 2018·Granted Sep 27, 2022·1 cites·20 claims
- 1879US11498964B2Antibody constructs for CDH19 and CD3AMGEN RES MUNICH GMBH·Filed 2018·Granted Nov 15, 2022·1 cites·17 claims
- 1979US2024327534A1B cell maturation antigen binding proteinsHARPOON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2078US12441796B2Antibody constructs for CDH19 and CD3AMGEN INC·Filed 2022·Granted Oct 14, 2025·0 cites·17 claims
- 2176US2024100157A1Mesothelin binding proteinsHARPOON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2271US11976125B2B cell maturation antigen binding proteinsHARPOON THERAPEUTICS INC·Filed 2021·Granted May 7, 2024·0 cites·20 claims
- 2371US2024084009A1Single chain variable fragment cd3 binding proteinsHARPOON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2470US12371504B2Trispecific proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2021·Granted Jul 29, 2025·0 cites·25 claims
- 2569US11607453B2Mesothelin binding proteinsHARPOON THERAPEUTICS INC·Filed 2020·Granted Mar 21, 2023·0 cites·19 claims
- 2662US2024084035A1Combination therapy with immune cell engaging proteins and immunomodulatorsHARPOON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2762US2020071405A1Antibody constructs for cdh19 and cd3AMGEN RES MUNICH GMBH·Filed 2019·Application pending·0 cites
- 2861US2021100902A1Prostate specific membrane antigen binding proteinHARPOON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2959US2021095047A1PSMA Targeting Trispecific Proteins and Methods of UseHARPOON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3059US2024336909A1Conditional activation of immunoglobulin moleculesHARPOON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3156US2024216518A1Extended-release immune cell engaging proteins and methods of treatmentHARPOON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3251US2020270362A1Msln targeting trispecific proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3349US2024228656A1Epcam targeting trispecific protein for treatment of cancerHARPOON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3447US2022054544A1Conditionally active receptorsHARPOON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3543US12415860B2Binding moiety for conditional activation of immunoglobulin moleculesHARPOON THERAPEUTICS INC·Filed 2019·Granted Sep 16, 2025·0 cites·20 claims
- 3643US2021269530A1Conditionally activated binding protein comprising a sterically occluded target binding domainHARPOON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3743US2021284728A1Dual binding moietyHARPOON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3841US2014189893A1Method of identifying compounds that specifically modulate the interaction of fgfr1 and beta klothoLI YANG·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bryan D. Lemon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →